VUG vs XBI
Vanguard Growth ETF vs SPDR S&P Biotech ETF
VUG$86.05
Vanguard Growth ETF
Large-cap US growth stocks.
Expense: 0.03%Yield: 0.40%
XBI$133.66
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.34%
Quick take
- • VUG has the lower expense ratio at 0.03% vs 0.35% for XBI.
- • VUG pays a higher dividend yield (0.40%).
Side-by-side metrics
| Metric | VUG | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.40% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $365.00B | $8.30B |
YTD return | 5.76% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.22 | 1.09 |
P/E ratio | 38.54 | — |
Last price | $86.05 | $133.66 |
Inception | — | — |
Issuer | Vanguard | State Street |
VUG top holdings
Top holdings · VUG
| NVDA | NVIDIA Corp | 13.32% |
| AAPL | Apple Inc | 12.32% |
| MSFT | Microsoft Corp | 9.09% |
| GOOGL | Alphabet Inc Class A | 5.54% |
| AMZN | Amazon.com Inc | 4.59% |
| AVGO | Broadcom Inc | 4.40% |
| GOOG | Alphabet Inc Class C | 4.39% |
| META | Meta Platforms Inc Class A | 4.15% |
| TSLA | Tesla Inc | 3.47% |
| LLY | Eli Lilly and Co | 2.60% |
Sector breakdown · VUG
Real Estate1.1%
Consumer Cyclical12.6%
Basic Materials0.7%
Consumer Defensive1.7%
Technology52.6%
Communication Services16.5%
Financial Services4.6%
Industrials4.6%
Energy0.4%
Healthcare5.4%
XBI top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%
About VUG
VUG (Vanguard Growth ETF) is Large-cap US growth stocks. Managed by Vanguard, the fund carries $365.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 0.40%. Its largest holding is NVIDIA Corp (NVDA), which represents 13.3% of the portfolio. Real Estate is the fund's largest sector exposure at 1.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.